Abstract:Epidemiological studies enable us to analyze disease behavior, define risk factors, and establish fundamental prognostic criteria. This study aimed to determine the epidemiological and clinical characteristics of canine tumors diagnosed during the years 2017-2021. The results showed that canine mammary tumors were the most common tumors, and their relative incidence for 5-years-total was 46.71% (504/1,079), with 48.41% (244/504) of benign, and 51.59% (260/504) of malignant. Pure breeds accounted for 84.13% (424/504) of submissions, and adult female dogs (9-12 years old) were most frequently involved, followed by 5-8-year-old females. Remarkably, 2.58% (13/504) occurred in the male dogs. In addition, a high prevalence of mammary tumors (77.38%, 390/504) was diagnosed in unneutered dogs, and different incidence rates were observed in different regions (Northeast, Southeast, Northwest and Southwest China). For clinical factors, the tumor size ranged from 0.5 to 28 cm, with the 0-5 cm being the most common tumor size (47.82%, 241/504), and malignant tumors (4.33 +/- 2.88 cm, mean +/- SD) were bigger than benign ones (3.06 +/- 1.67 cm, mean +/- SD) (p < 0.001). The incidence of single tumor (55.36%, 279/504) was higher than that of multiple tumors in dogs, while the latter had a higher incidence of malignant tumors (74.67%, 168/225). According to this study, we also found that canine mammary tumors were more common in the last two pairs of mammary glands. In addition, multiple linear regression analysis showed that there was linear significant relationship between three independent variables (age, tumor size, and tumor number) and histological properties of canine mammary tumor [(p>|t|) < 0.05]. This is the first retrospective statistical analysis of such a large dataset in China to reveal the link between epidemiological clinical risks and histological diagnosis. It aids in the improvement of the host's knowledge of canine tumor disorders and the early prevention of canine mammary tumors.

Clinico-Pathological, Immunohistochemical and In-Situ TUNEL ASSAY Observations of Canine Breast Tumors

The Analysis of E-Cadherin, N-Cadherin, Vimentin, HER-2, CEA, CA15-3 and SF Expression in the Diagnosis of Canine Mammary Tumors.

Integrated Study of Canine Mammary Tumors Histopathology, Immunohistochemistry, and Cytogenetic Findings

Diagnosis of Canine Tumours and the Value of Combined Detection of VEGF, P53, SF and NLRP3 for the Early Diagnosis of Canine Mammary Carcinoma

Research progress of good markers for canine mammary carcinoma

Epidemiological Investigation of Canine Mammary Tumors in Mainland China Between 2017 and 2021

Detection of tumor necrosis factor-1 in canine mammary tumor tissues by fluorescent real-time polymerase chain reaction(PCR)

Histopathologic Diagnoses and Analyses of 38 Cases of Canine Tumors

Relation between expressions of PTEN and VEGF and clinicopathological features in canine mammary gland tumors

Expression of PTEN Gene and Its Clinical Value in Canine Mammary Tumors

Characterization of the Proliferation State in Canine Mammary Tumors by the Standardized AgNOR Method with Postfixation and Immunohistologic Detection of Ki-67 and PCNA

Histopathological observations of canine mammary gland tumors and expression analysis of tenascin-C

Expression and Significance of IL-6 and IL-8 in Canine Mammary Gland Tumors

PD-L1 mRNA and protein expression in canine mammary carcinomas: Correlation with histopathological grade and molecular markers

Expression and significance of p63 and Calponin proteins in canine mammary tumors

Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology

Expression and Significance of PTEN in Canine Mammary Gland Tumours

Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026

Long-term Assessment of Risk Factors for Canine Tumors Registered in Xi'an, China

Histopathological observation on canine breast tumor mixed with cartilaginous components

Novel promising serum biomarkers for canine mammary tumors